货号:GS40679
Sudubrilimab (HS636) is a humanized IgG1 kappa monoclonal antibody targeting programmed death-ligand 1 (PD-L1, CD274). It binds to PD-L1 on tumor cells and immune cells, blocking its interaction with PD-1 and B7-1 (CD80) to restore T cell-mediated anti-tumor immunity. It is being developed for the treatment of advanced solid tumors, such as non-small cell lung cancer and esophageal carcinoma.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯